NASDAQ : HYPD
Hyperion DeFi, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 3.505 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 54.47M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 48.48M |
| Enterprise Value | 47.76M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 15.54M |
| Shares Outstanding | 15.54M |
| Shares Change (YoY) | +401.12% |
| Shares Change (QoQ) | +34.32% |
| Owned by Insiders (%) | 11.51% |
| Owned by Institutions (%) | 18.11% |
| Float | 13.75M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 0.55 |
| PS Ratio | 35.39 |
| Forward PS | 11.53 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 34.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.34 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.47 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 9.55% |
| Return on Assets (ROA) | -11.07% |
| Return on Invested Capital (ROIC) | -11.92% |
| Return on Capital Employed (ROCE) | -13.88% |
| Weighted Average Cost of Capital (WACC) | 16.55% |
| Revenue Per Employee | $155,633 |
| Profits Per Employee | -$1.98M |
| Employee Count | 9 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.52 |
| 52-Week Price Change | -50.77% |
| 50-Day Moving Average | 3.43 |
| 200-Day Moving Average | 3.36 |
| Relative Strength Index (RSI) | 48.67 |
| Average Volume (20 Days) | 273,907 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.30M |
| Short Previous Month | 1.13M |
| Short % of Shares Out | 8.34% |
| Short % of Float | 9.43% |
| Short Ratio (days to cover) | 2.74 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.40M |
| Gross Profit | 1.10M |
| Operating Income | -14.94M |
| Pretax Income | 6.65M |
| Net Income | -17.85M |
| EBITDA | n/a |
| EBIT | -14.94M |
| Loss Per Share | -$1.83 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.64M |
| Total Debt | 8.91M |
| Net Cash | 725,297 |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 101.93M |
| Book Value Per Share | 6.66 |
| Working Capital | 7.40M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -13.97M |
| Capital Expenditures | 22,959 |
| Depreciation & Amortization | n/a |
| Net Borrowing | -235,558 |
| Free Cash Flow | -13.95M |
| FCF Per Share | -$0.90 |
Margins
| Measure | Value |
|---|
| Gross Margin | 78.35% |
| Operating Margin | -1,066.76% |
| Pretax Margin | 474.87% |
| Profit Margin | 474.87% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -401.12% |
| Shareholder Yield | -401.12% |
| Earnings Yield | -58.54% |
| FCF Yield | -28.14% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $9.83 |
| Price Target Difference | 214.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 141.80% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 3, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:80 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.54 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |